and return on financial instruments decreased of Baht 22.50 million from gain from investment in securities decreased of Baht 21.79 million due to loss from investment in equity securities increased of
increased by Baht 256 million, driven by increase of profit during the period, partly offset by dividend payment. Key Financial Performance Q2 2018 Q3 2018 Q4 2018 Q1 2019 Q2 2019 Return on equity (ROE) 18.90
shareholders' equity as Part of the changes the proportion of subsidiary. Ratio Analysis Financial Statement year ended June 30, 2018 Return on Assets and Return on Equity in 6 months 2018 improved from 11% and
September 30, 2018 Return on Assets and Return on Equity in 9 months 2018 improved from 12.9% and 14.6% to 13.5% and 19.9% yoy. It was driven by the outstanding profit for the Company and its subsidiary. In
Supervisory Board concerning Rules of Management for Retail Funds, Non-retail Funds, Funds for Institutional Investors and Private Funds; “complex return mutual fund” means a mutual fund that offers return to
% Efficiency Ratios Return on Equity (%) 15.44% 15.32% 17.67% Return on Assets (%) 10.87% 10.68% 12.25% Return on fixed assets (%) 82.27% 89.99% 116.94% Asset turnover times 1.14 1.09 1.06 Financial Policy
(%) 5.69% 9.51% 9.80% Return on Equity (%) 8.82% 15.44% 15.32% Efficiency Ratios Return on Assets (%) 6.27% 10.87% 10.68% Return on fixed assets (%) 46.78% 82.27% 89.99% Asset turnover times 1.10 1.14 1.09
with higher administrative expenses. 4 (Unit: Baht million) Consolidated balance sheets As at 31st Mar 2019 As at 31st Mar 2018 Amount % Amount % Assets Current Assets Cash and cash equivalents 314.32
was mainly from the higher in gross margin. 4 (Unit: Baht million) Consolidated balance sheets As at 31st Mar 2018 As at 31st Mar 2017 Amount % Amount % Assets Current Assets Cash and cash equivalents
performance that leads to value-added contribution to the shareholders. Size of the transaction calculated by criteria for total value of the return from = 269.96*100 consolidated financial statements as of